Paliperidone Palmitate Chemical Properties

Melting point:

110-115°C

Boiling point:

736.3±70.0 °C(Predicted)

Density 

1.19

storage temp. 

Sealed in dry,Store in freezer, under -20°C

solubility 

Chloroform (Slightly), Ethyl Acetate (Slightly, Heated, Sonicated), Methanol (Slightly)

form 

Solid

pka

8.07±0.10(Predicted)

color 

Off-White to Light Beige

InChIKey

VOMKSBFLAZZBOW-UHFFFAOYSA-N

SMILES

C(OC1C2N(CCC1)C(=O)C(CCN1CCC(C3C4=C(ON=3)C=C(F)C=C4)CC1)=C(C)N=2)(=O)CCCCCCCCCCCCCCC

Safety Information

WGK Germany 

WGK 3

Storage Class

6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects

Hazard Classifications

Acute Tox. 3 Oral

Paliperidone Palmitate Usage And Synthesis

Description

Paliperidone palmitate is an atypical long acting antipsychotics，which can fast onset in acute phase and continuously improve the symptoms in maintenance phase． It has the solid efficacy and convenient ad[1]ministration，which offer a new option for schizophrenia treatment and will help patients to adhere the treatment and prevent relapse． As the sole long acting antipsychotics with monthly injection，it was approved by CFDA in 2011 and indicated for the acute and maintenance treatment of schizophrenia．

Uses

Paliperidone Palmitate is a long-acting injectable atypical antipsychotic used in the treatment of schizophrenia.

Definition

ChEBI: 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl hexadecanoate is a fatty acid ester obtained by the formal condensation of the carboxy group of hexadecanoic acid with the hydroxy group of 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one. It is a member of 1,2-benzoxazoles, a heteroarylpiperidine, an organofluorine compound, a pyridopyrimidine and a fatty acid ester.

Side effects

The review of the literature also underlined that paliperidone palmitate is well tolerated, compared with placebo. Frequency and severity of side-effects such as extrapyramidal symptoms, hyperprolactinemia and weight gain, was similar or less than those found in treatment with other atypical antipsychotics, including long-acting ones.

Synthesis

Aseptic air-flow mill was used to control the crushing pressure of 3~5bar, and the sterile paliperidone palmitate was crushed to the effective particle size of 2~15μm. Weighed 12g of sodium carboxymethyl cellulose, placed in about 500ml of injectable water, dissolved, dissolved; and then took 15g of injectable polysorbate 80, 40g of mannitol, 0.9g of sodium dihydrogen phosphate, stirred to dissolve, and then adjust the pH value to 7.0 by using 0.5 M sodium hydroxide solution to adjust the pH to 7.0. Weigh 312g of micronized sterile papanicolone palmitate was added to the above solution, stirred and sheared until uniformly dispersed, replenished with water for injection, and the volume of the material was fixed to 1000 ml, to obtain the aseptic papanicolone palmitate suspension with an effective particle size in the range of 2~15μm.

Paliperidone Palmitate(199739-10-1)Related Product Information

• 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methylpyrido[1,2-a]pyrimidin-4-one
• Paliperidone E-Oxime
• Isooctyl palmitate
• Clindamycin palmitate hydrochloride
• Paliperidone
• Paliperidone Impurity 4
• 2,4-Difluorophenyl-(4-piperidinyl)methanone oxime hydrochloride
• Isopropyl palmitate
• Ethylhexyl Palmitate
• Clindamycin palmitate hydrochloride
• Vitamin A palmitate
• PALMITELAIDIC ACID
• Paliperidone N-Oxide
• 9-hydroxy-2-methyl-3-vinyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
• (R)-9-Hydroxy Risperidone
• (S)-9-Hydroxy Risperidone
• 3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
• RAC 9-HYDROXYRISPERIDONE-D4